APSSA / SAAPI Friday, 4 October 2013 07h00-10h00 TEA & REGISTRATION JOPENING AND WELCOME JOINT SESSION : CHAIR Prof Sarel Malan o i10h00-10h15
Opening and introduction of Minister of Health
Prof Sarel Malan (UWC) Theuns Botha (Minister of Health, Western Cape) S11h00-11h30 Key challenges faced in each sector ICPA-Sham Moodley : Academy-Dr Shirley-Anne Boschmans : SAAPI-Robyn Daniel Mr Scott Senwelo (Past President Botswana Pharmaceutical Society)
International Non-Proprietary Names (INN) Programme
Dr Raffaella Balocco - WHO i12h50-13h00 Q&A 13h00-14h30 Opening of Exhibition & Lunch ACADEMIC SESSION 1: Nanoscience, Drug Design & ADHERENCE SESSIONS : CHAIR Sham Moodley Discovery CHAIR: Prof S van Dyk Per Troein - IMS
14h30-15h00 Drug carriers and particulate drug delivery
Prof V Torchilin
The influence of C5 and C6 substitution on the
Per Troein - IMS
monoamine oxidase B inhibitory activity of
Dr M van der Walt
Eco-friendly and cost-effective, synthesis
Using motivational interviews in adherence
Prof Angeni Bheekie
15h20-15h40 processes for potential active pharmaceutical
Dr B Samant
An insight into diverse computational methods
pharmaceutical application for Deaf users and
Mrs M Parker Ms S Moonsamy
In Silico Quantitation of the Molecular Energy
Ms L du Toit / Prof
16h00-16h30 and Surface Attributes of Multi-Modal
16h30-17h00 Tea in Exhibition Centre ACADEMIC SESSION 2: Pharmacy Education BUSINESS OF PHARMACY : CHAIR Verity Izeboud CHAIR: Dr S Burton B17h00-17h25 Value of Pharmacy Data Ms Linda Reid-IMS Dr J Joubert Ms Lullu Krugel-KPMG 17h20-17h40 Factors in flipping the pharmacology classroom
Interdisciplinary Learning: Joint Patient
17h40-18h00 Encounters with Undergraduate Medical and
Mrs D Johnston 19h00-22h00 Dinner in Exhibition Center - Platinum Sponsor speech Saturday, 5 October 2013 ACADEMIC SESSION 3: Natural Products CHAIR: NATIONAL HEALTH INSURANCE : CHAIR Solly Suleman Dr I Vermaak
Breakfast session on Hypertension: Sponsored by
Prof Bryan Rayner
Biogaran. ACT TODAY……. For tomorrow. t08h55-09h00 Welcome and Speaker Intro Solly Suleman Prof M Heinrich Prof M Davies-
09h20-09h50 Marine drug discovery in South Africa
SASBCP AGM
Challenges in quality control of herbal medicines -
Prof A Viljoen Prof Nadine Butler
Assessing equity in the distribution of community
Modelling of flavonoid glycoside dissolution from
pharmacies in preparation for the NHI: Role of
Ms O Mbamalu Dr Kim Ward
different Sutherlandia frutescens materials
independent community pharmacy and public
clinics. Metropolitan Clinics in Independent Community
Rene Anderson-MHG
10h30-10h35 Intro to tea poster presentation
Prof N Butler 10h30-11h00 TEA & POSTER PRESENTATION YOUNG SCIENTISTS SESSION 1 CHAIR: ACADEMIC SESSION 4: Therapeutics REMUNERATION : CHAIR: Elze Rossouw Dr K Obikeze CHAIR: Prof T Brink
A rapid and reproducible HPLC method for the
11h00-11h15 quantification of fucoxanthin from marine brown
Mr B Mubaiwa Jackie Maimin
The antioxidant properties of bufadienolides
11h15-11h30 analogous to the orbicusides of Cotyledon
Ms J Aucamp Prof D Oliver Ms S Mostert
[(phenylethyl)sulfanyl]caffeine analogues
Ethical Responsibility vs Funding Control
Andy Gray - FIP
Novel aminoquinoline-polycyclic molecules as
11h45-12h00 potential antimalaria agents against Plasmodium Mr E Fortuin
An in vitro multi-parametric assessment of the
Monoamine oxidase inhibitory activities of
Mrs C Minders
hepatotoxic effects of Acokanthera oppositifolia
Mr W Cordier Dr Inez Naidu-DH Amos Masango-SAPC
Antidepressant properties of azure B and a
Mrs A Delport
Services. A debate between SAPC, Discovery
Johan Raats-PCDT
An assessment of factors influencing adolescent
-12h00-13h00 Health, Gems, Metropolitan and PCDT Zohra Mahomed-MHG
12h30-12h45 pregnancy in two rural Eastern Cape
Ms A Siruma
Pharmacists with Dr Kruger. Chaired by Andy
GEMS, Dr Johann
HER-2 positive breast cancer: Which cytotoxic
Kruger- President
Assessment of potential drug-drug interactions
agent best compliments Trastuzumab's efficacy
Miss T Hurrell
12h45-13h00 among South African children and adolescents
Mr C Van Rooyen 13h00-14h00 JOINT SESSION J14h00-14h30 Advances in Treatment of Epilepsy Prof Barry Gidal
Future of Pharmacovigilance in South Africa
Prof Banoo n15h0015h10 15h10-15h30 TEA & POSTER PRESENTATION YOUNG SCIENTISTS SESSION 2 SASBCP YOUNG SCIENTIST BEST PEER PRACTICES : CHAIR Mogologolo Phasha CHAIR: Mr N Ebrahim CHAIR: Mr S Amod
Cost Comparison between Repackaging Bulk OralSolid Medicines and Manufacturer-Prepared
Johan Raats
15h30-15h45 Patient-Ready Packs in the Public Sector in South Mr A Abahamye
Pharmacokinetics of para-aminosalicylic acid
Work-related basic need satisfaction of pharmacy
Ms C Coetzer
given once or twice daily to adult MDR/XDR TB
Ms L de Kock Tiny van Schalkwyk & Brian Thomas
The synthesis and evaluation of quinolinone
Ms L Meiring
derivatives as inhibitors of monoamine oxidase
In vitro drug screening of potential novel
Haldane Murray, Tiny
Novel tricycloundecane derivatives as potential N-
Insuring your valuables- Assets and Staff
Mr A Egunlusi Ms D Steyn & Warren Dean
channel inhibitors for neuroprotection.
Synthesis of 3, 4-dihydropyrimidine-2(1H)-ones
The effect of early-life exposure of rats to
16h30-16h45 and -imines as adenosine A1 and A2A
Ms R Katsidzera
Venlafaxine on behaviour and neurobiological
Mr R Kruger
markers of antidepressant action in adulthood
Gary Hendrickse
Synthesis of naphthoquinone derivatives as
The kinetic evaluation of the inhibitory potential
potential anti-trypanosomal agents against
of a polyherbal tea mixture and its constituents
Ms C Chakaingesu Mrs V Paddy
Synthesis of polycyclic non-steroidal anti-
inflammatory prodrugs and their biological
Prescribing error in three adult wards at a
17h00-17h15 evaluation as potential therapeutic agents in
Ms M Abaniwonda Mr M Vally
Design, synthesis and biological evaluation of 2-
17h15-17h30 aminopyrimidines as dual adenosine A1 and A2A Ms J Kleynhans ACADEMIC SESSION 5
Factors affecting adherence rates to highly active
Development and assessment of captopril loaded
antiretroviral therapy among patients attending
Dr NL Katende- Ms S Mukozhiwa
a public health care facility in Mthatha, Eastern
Inflammation as a contributing factor in the
Mr P Makoni
Development and evaluation of efavirenz-loaded
pathophysiology of schizophrenia: pre-clinical
Dr M Möller 19h00-22h00 Evening function Sunday, 6 October 2013 08h00-09h00 Kobus le Roux 08h00-09h00 APSSA AGM JOINT SESSION J09h00-09h15 Address and Launch of Adherence Institute. Mr Sham Moodley
Awards Ceremony -Academy Oath Taking Ceremony
Dr Shirley-Anne Boschmans / Prof Nadine Butler n09h45-10h15 Developing medicines for emerging markets Dr Dushen Chetty (GSK) Dominique Jordan - President CPS FIP Foundation e11h00-11h15 Thank you to exhibitors/sponsors Kobus le Roux 11h15-11h45 WORKSHOPS & PRACTICAL SESSIONS WORKSHOP 1 WORKSHOP 2 WORKSHOP 3 WORKSHOP 4 WORKSHOP 5 Pharmacovigilan Asthma Management (Assessing the Asthma Preparing a Paper for Frail Care Opportunities in Community Pharmacy Motivational Interviews in Adherence by ce Awareness Patient, Clinical Measurements, Treatment Publication by (Incontinence, Wound Care, Chronic Meds) by Prof Angeni Bheekie, Dr Mea van Huyssteen, Prof Nadine within your daily Guidelines) by Dr Prof Michael Heinrich Sister Anne Berzen. Sponsored by Smith & Nephew. environment by Shaunagh Emanual Aadila Patel o p s13h15-14h30 LUNCH AND DEPARTURE
Educant la consciència, actuant en conseqüència TRES ARTICLES DE BA JIN (LI PEI KAN) SOBRE ELS PROBLEMES DE L’ANARQUISME I LA REVOLUCIÓ XINESA Vera Z19/07/2008www.alasbarricadas.orgTraducció al castellà de José Antonio Gutiérrez DantonExtret de: anarkismo.net Li Pei Kan (Ba Jin) al 1928 Els següents tres articles, disponibles per primera vegada en castellà, han estat es
The new immune system medications provide true disease man-agement for the first time. They clearly are not for everyone withMS and must be selected and used with expert advice. The back-bone to MS management has been and continues to be the man-agement of symptoms. Everyone with MS should be aware of themany ways that the symptoms of MS can be managed, with the goalof improved quality of life. S